Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (251-260 of 525) with videos related to

Pageof 53
Sort By:
Plos Pathogens|May 11, 2018
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteinsTorben Schiffner, Jesper Pallesen, Rebecca A Russell, et al.
Scientific Reports|May 29, 2026
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersYves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Viruses|December 23, 2022
Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus MacaquesBapi Pahar, Wayne Gray, Marissa Fahlberg, et al.
Vaccine|October 20, 2006
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul A Goepfert, Georgia D Tomaras, Helen Horton, et al.
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Journal of Virology|July 29, 2016
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus MacaquesSmita S Iyer, Sailaja Gangadhara, Blandine Victor, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
The Journal of Infectious Diseases|December 13, 2024
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell LinesGregory J Wilson, L W Preston Church, Colleen F Kelley, et al.
Pageof 53

Showing results (251-260 of 525) with videos related to

Sort By:
Pageof 53
Plos Pathogens|May 11, 2018
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteinsTorben Schiffner, Jesper Pallesen, Rebecca A Russell, et al.
Scientific Reports|May 29, 2026
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersYves Levy, Christiane Moog, Aurélie Wiedemann, et al.
Viruses|December 23, 2022
Recombinant Simian Varicella Virus-Simian Immunodeficiency Virus Vaccine Induces T and B Cell Functions and Provides Partial Protection against Repeated Mucosal SIV Challenges in Rhesus MacaquesBapi Pahar, Wayne Gray, Marissa Fahlberg, et al.
Vaccine|October 20, 2006
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul A Goepfert, Georgia D Tomaras, Helen Horton, et al.
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Journal of Virology|July 29, 2016
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus MacaquesSmita S Iyer, Sailaja Gangadhara, Blandine Victor, et al.
Plos Pathogens|March 15, 2021
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection riskErica Andersen-Nissen, Andrew Fiore-Gartland, Lamar Ballweber Fleming, et al.
Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
The Journal of Infectious Diseases|December 13, 2024
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell LinesGregory J Wilson, L W Preston Church, Colleen F Kelley, et al.
Pageof 53